Orrick advised BioAtla on the deal. Clinical-stage biotechnology company BioAtla, Inc. (Nasdaq: BCAB) announced the sale of 9,745,128 shares of its common stock at a price of...
BioAtla’s $65 Million Underwritten Offering of Common Stock
Peloton Capital Management and Stephen Smith’s Acquisition of Glass Lewis
Perkins Coie LLP advised Peloton Capital Management and Stephen Smith on the deal. Peloton Capital Management and Stephen Smith announced the acquisition of Glass Lewis from the...